Celldex Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
September 22 2017 - 8:00AM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that
Anthony Marucci, Co-founder, President and Chief Executive Officer,
will present a corporate overview at the Cantor Fitzgerald Global
Healthcare Conference on September 26, 2017 at 11:30 a.m. EDT in
New York.
The live webcast will be available on the "Events &
Presentations" page of the "Investors & Media" section of the
Celldex website. A replay will be available for seven days
following the event.
About Celldex Therapeutics, Inc.Celldex is
developing targeted therapeutics to address devastating diseases
for which available treatments are inadequate. Our pipeline
includes antibodies, antibody-drug conjugates and other
protein-based therapeutics derived from a broad set of
complementary technologies which have the ability to engage the
human immune system and/or directly inhibit tumors to treat
specific types of cancer or other diseases. Visit
www.celldex.com.
Company Contact
Sarah CavanaughSenior Vice President, Corporate Affairs &
AdministrationCelldex Therapeutics, Inc.(781)
433-3161scavanaugh@celldex.com
Charles LilesAssociate Director, Investor Relations & Corp
CommunicationsCelldex Therapeutics, Inc.(617)
383-3433cliles@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024